Sarepta Therapeutics, Inc. Annual Current State and Local Tax Expense (Benefit) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Sarepta Therapeutics, Inc. annual/quarterly Current State and Local Tax Expense (Benefit) history and growth rate from 2017 to 2023.
  • Sarepta Therapeutics, Inc. Current State and Local Tax Expense (Benefit) for the quarter ending June 30, 2023 was $10.5M.
  • Sarepta Therapeutics, Inc. annual Current State and Local Tax Expense (Benefit) for 2023 was $11.1M, a 15.8% decline from 2022.
  • Sarepta Therapeutics, Inc. annual Current State and Local Tax Expense (Benefit) for 2022 was $13.2M.
  • Sarepta Therapeutics, Inc. annual Current State and Local Tax Expense (Benefit) for 2021 was -$40K, a 106% decline from 2020.
Current State and Local Tax Expense (Benefit), Annual (USD)
Current State and Local Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.1M -$2.08M -15.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $13.2M +$13.2M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$40K -$664K -106% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $624K +$103K +19.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $521K +$1.04M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$521K -$2.38M -128% Jan 1, 2018 Dec 31, 2018 10-K 2022-03-01
2017 $1.86M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.